TT

Tom Thomas

Investor @ Newpath Partners

Boston, Massachusetts

VC
Investor

Invests in

Locations:

  • Min Investment:

    $500,000.00

  • Max Investment:

    $40,000,000.00

  • Target Investment:

    $10,000,000.00

Skills

Corporate Strategy
Project Portfolio Management
Start-up Ventures
Start-up Leadership
Early Stage Investment
New Venture Development
Healthcare Investing
Cell Culture
Molecular Biology
Genetics
Clinical Research
Research
Biochemistry
Cancer Research
Cancer
Tumor Immunology
Stem Cell Research
Cancer Stem Cells
Tissue Culture
Metabolism

Education

Lists including Tom

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

AT
AE
AE
AL

All Pre-Seed Investors

7972 people

SF
SS
ST
SJ

Pre-Seed Investors in Boston

71 people

Work Experience

NP
Newpath Partners

2024

  • Investor

    2024

MB
Magnet Biomedicine

2024

  • Board Observer

    2024

ET
Exo Therapeutics

2024

  • Board Director

    2024

KT
Kisbee Therapeutics

2024 - 2025

  • Board Observer

    2024 - 2025

SM
Sera Medicines, LLC

2023 - 2024

  • Founding Team

    2023 - 2024

RC
RA Capital Management, L.P.

2022 - 2024

  • Healthcare Associate

    2022 - 2024

PM
Prologue Medicines

2021 - 2022

  • Founding Team

    2021 - 2022

FP
Flagship Pioneering

2020 - 2022

  • Associate

    2020 - 2022

  • Fellow

    2020 - 2020

EC
Emmanuel College (Boston)

2018 - 2020

  • Adjunct Faculty of Biology

    2018 - 2020

    School of Health Sciences; Department of Biology Courses: Anatomy & Physiology, Endocrinology, Microbiology, Human Biology

HM
Harvard Medical School

2017 - 2020

  • Research Fellow

    2017 - 2020

    Laboratory of Jon C Aster MD, PhD; Brigham & Women’s Hospital Laboratory of Stephen Blacklow MD, PhD; Harvard Medical School